JESSICA WOLTERS: Open Payments
NPI 1750016937 · SALINA, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$697 in 32 payments from 25 companies in 2025. Trend: 2023 $487 · 2024 $753 · 2025 $697
Food & beverage: $697
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 3 | $78 |
| Regeneron Healthcare Solutions, Inc. | 2 | $64 |
| Merck Sharp & Dohme LLC | 2 | $48 |
| Novartis Pharmaceuticals Corporation | 2 | $42 |
| Incyte Corporation | 2 | $39 |
| Janssen Biotech, Inc. | 2 | $30 |
| Dendreon Pharmaceuticals LLC | 1 | $29 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $29 |
| TAIHO ONCOLOGY, INC. | 1 | $27 |
| GlaxoSmithKline, LLC. | 1 | $24 |
Products named: LIBTAYO, KEYTRUDA, NINLARO, PROVENGE, LONSURF, PLUVICTO, IMFINZI, Doptelet.
Industry payments across KS — which companies pay providers there.
